Digitally Delivered Treatments to Reduce Chronic Low Back Pain
- NCT ID
- NCT06984354
- Registry status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Neuroscience Research Australia
- Conditions
- Chronic Pain (Back / Neck), Digital Health, General Practice (GP), Primary Care Settings, Hypnosis, Chronic Pain Management, Low Back Pain, Patient Education
Overview
ClinicalTrials.gov lists this study as Recruiting.
Official title: NOTUS Trial: A Randomised Controlled Trial of Two Digitally Delivered Treatment Options for Chronic Back Pain
Enrollment: 720 participants (Estimated).
What is being studied
- Behavioral: Guideline-informed factsheet
- Behavioral: Pain education and clinical hypnosis delivered via a mobile app
Who may be eligible
- Ages
- 18 Years to no maximum
- Sex
- All
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Study locations
1 study location is listed.
Recruiting site status is explicitly provided for 1 location; 1 is listed as Recruiting.
Countries: Australia
- New South Wales, Australia: 1
Sample of listed locations
- Neuroscience Research Australia — Randwick, New South Wales, 2031, Australia — Recruiting
Study details
- Start date
- June 2, 2025
- Primary completion date
- May 26, 2027
- Completion date
- May 26, 2028
- First posted
- May 22, 2025
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT06984354
- Registry last updated
- August 14, 2026
- QualifiedStudies registry data refreshed
- October 5, 2026
- QualifiedStudies record fetched
- October 5, 2026
View NCT06984354 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Neck Pain studies | Clinical trial FAQ